As of 2025-07-15, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 65.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.43 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 41.4%.
The range of the Relative Valuation is 54.21 - 75.41 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 28.3x | 27.1x |
| Forward P/E multiples | 20.4x - 24.5x | 22.2x |
| Fair Price | 54.21 - 75.41 | 65.64 |
| Upside | 16.8% - 62.4% | 41.4% |
| Date | P/E |
| 2025-07-14 | 17.78 |
| 2025-07-11 | 17.60 |
| 2025-07-10 | 18.22 |
| 2025-07-09 | 17.90 |
| 2025-07-08 | 17.67 |
| 2025-07-07 | 17.46 |
| 2025-07-03 | 17.62 |
| 2025-07-02 | 17.89 |
| 2025-07-01 | 17.84 |
| 2025-06-30 | 17.38 |
| 2025-06-27 | 17.41 |
| 2025-06-26 | 17.52 |
| 2025-06-25 | 17.53 |
| 2025-06-24 | 17.66 |
| 2025-06-23 | 17.62 |
| 2025-06-20 | 17.60 |
| 2025-06-18 | 17.59 |
| 2025-06-17 | 17.74 |
| 2025-06-16 | 18.27 |
| 2025-06-13 | 18.68 |
| 2025-06-12 | 19.04 |
| 2025-06-11 | 18.84 |
| 2025-06-10 | 18.77 |
| 2025-06-09 | 18.40 |
| 2025-06-06 | 18.18 |
| 2025-06-05 | 17.97 |
| 2025-06-04 | 18.01 |
| 2025-06-03 | 18.06 |
| 2025-06-02 | 18.32 |
| 2025-05-30 | 18.13 |
| 2025-05-29 | 17.97 |
| 2025-05-28 | 17.64 |
| 2025-05-27 | 17.61 |
| 2025-05-23 | 17.59 |
| 2025-05-22 | 17.66 |
| 2025-05-21 | 17.65 |
| 2025-05-20 | 17.98 |
| 2025-05-19 | 17.73 |
| 2025-05-16 | 17.56 |
| 2025-05-15 | 17.20 |
| 2025-05-14 | 16.57 |
| 2025-05-13 | 17.50 |
| 2025-05-12 | 18.09 |
| 2025-05-09 | 17.44 |
| 2025-05-08 | 17.61 |
| 2025-05-07 | 17.88 |
| 2025-05-06 | 17.86 |
| 2025-05-05 | 18.80 |
| 2025-05-02 | 18.99 |
| 2025-05-01 | 18.63 |